Organic and synthetic cannabinoid use in adolescents

Pediatric Annals

Volumn 42, Issue 1, 2013, Pages 31-35

  Bhatty, Sanaa ^a   Wu, Wendell ^b  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; BENZODIAZEPINE; CANNABINOID; CANNABIS; DRONABINOL; NEUROLEPTIC AGENT; PLACEBO; PSYCHOTROPIC AGENT;

ADOLESCENT; ANXIETY; ARTICLE; COMORBIDITY; DRUG ABUSE; DRUG DEPENDENCE; EUPHORIA; HUMAN; MOTOR COORDINATION; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); WITHDRAWAL SYNDROME;

ADOLESCENT; ADOLESCENT BEHAVIOR; CANNABINOIDS; HUMANS; MARIJUANA ABUSE; PEDIATRICS; PRIMARY HEALTH CARE; STREET DRUGS; UNITED STATES;

EID: 84872782582     PISSN: 00904481     EISSN: None     Source Type: Journal    
DOI: 10.3928/00904481-20121221-16     Document Type: Article

References (30)

1. Youth Risk Behavior Surveillance-United States, 2011. Available at: www.cdc.gov/mmwr/pdf/ss/ss6104.pdf. Accessed Dec. 3, 2012.
2. Synthetic Drugs (a.k.a. K2, Spice, Bath Salts, etc.) Office of National Drug Control Policy. Available at: www.whitehouse.gov/ondcp/ondcp-fact-sheets/synthetic-drugs-k2-spicebath-salts. Accessed on Dec. 3, 2012.
3. Johnston LD, O'Malley PM, Bachman JG, et al. Monitoring the future national results on adolescent drug use: Overview of key findings, 2011. Ann Arbor: Institute for Social Research, The University of Michigan. Available at www.monitoringthefuture.org. Accessed Dec. 3, 2012.
4. Bailey JA, Dupont RL, Teitelbaum, SA, et al. Cannabis Use Disorders: Epidemiology, Comorbidity, and Pathogenesis. In Basow, DS (ed). UpToDate. Waltham, MA: UpToDate; 2012.
5. Ashton C. Pharmacology and effects of cannabis: a brief review. Br J Psychiatry. 2001;178:101-106.
6. Macher R, Burke T, Owen S. Synthetic Marijuana. FBI Law Enforcement Bulletin: May 2012. Available at: www.fbi.gov/stats-services/publications/law-enforcement-bulletin/may-2012/synthetic-marijuana. Accessed Dec. 3, 2012.
7. Fattore L, Fratta W. Beyond THC: the new generation of cannabinoid designer drugs. Front Behav Neurosci. 2011;5:60.
8. Controlled Substance Schedules. US Department of Justice, Drug Enforcement Administration. Last reviewed: September 2012. Available at: www.deadiversion.usdoj.gov/schedules/index.html. Accessed Dec. 3, 2012.
9. 18 Legal Medical Marijuana States and DC: Laws, Fees, and Possession Limits. Available at: medicalmarijuana. procon. org/view. resource. php?resourceID=000881. Accessed December 3, 2012.
10. American Psychiatric Association. The Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV TR). Washington, DC: American Psychiatric Association Press; 2000.
11. DuPont JL, Bailey JA, Teitelbaum SA, et al. Cannabis use disorders: clinical features and diagnosis. In Basow, DS (ed). UpToDate. Waltham, MA: UpToDate; 2012.
12. Hasin DS, Keyes KM, Alderson D, et al. Cannabis withdrawal in the United States: results from NESARC. J Clin Psychiatry. 2008;69:9.
13. Budney AJ, Hughes JR, Moore BA, Vandrey R. Review of the validity and significance of cannabis withdrawal syndrome. Am J Psychiatry. 2004;(11)161.
14. Cohen J, Morrison S, Greenberg J, Saidinejad M. Clinical presentation of intoxication due to synthetic cannabinoids. Pediatrics. 2012;129(4):e1064-e1067.
15. American Psychiatric Association. American Psychiatric Association Board of Trustees Approves DSM-5. Diagnostic manual passes major milestone before May 2013 publication. [press release] Dec. 1, 2012. Available at www.psych.org. Accessed Dec. 5, 2012.
16. Curley B. DSM-V Draft includes major changes to addictive disease classifications. February 12, 2010. Available at: www.drugfree.org/join-together/addiction/dsm-vdraft-includes-major. Accessed Dec. 5, 2012.
17. Tetrault JM, Crothers K, Moore BA, et al. Effects of marijuana smoking on pulmonary function and respiratory complications: a systematic review. Arch Intern Med. 2007;167(3):221-228.
18. Hashibe M, Straif K, Tashkin DP, et al. Epidemiologic review of marijuana use and cancer risk. Alcohol. 2005;35(3):65-275.
19. Adams IB, Martin BR. Cannabis: pharmacology and toxicology in animals and humans. Addiction. 1996;91(11):1585.
20. Thomson W, Poulton R, Broadbent JM, et al. Cannabis smoking and periodontal disease among young adults. JAMA. 2008;299(5):525-531.
21. Meier MH, Caspi A, Ambler A, et al. Persistent cannabis users show neuropsychological decline from childhood to midlife. Proc Natl Acad Sci U S A. 2012; 109(40):2657-2664.
22. Grant I, Gonzalez R, Carey CL, et al. Nonacute (residual) neurocognitive effects of cannabis use: a meta-analytic study. J Int Neuropsychol. 2003;9:679-89.
23. Moore TH, Zammit S, Lingford-Hughes A, et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet. 2007;370(9584):319-328.
24. Large M, Sharma S, Compton MT, et al. Cannabis use and earlier onset of psychosis: a systematic meta-analysis. Arch Gen Psychiatry. 2011;68(6):555.
25. Caspi A, Moffitt TE, Cannon M, et al. Moderation of the effect of adolescentonset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene x environment interaction. Biol Psychiatry. 2005;57(10):1117-1127.
26. Castellanos D, Thornton, G. Synthetic cannabinoid use: recognition and management. J Psychiatr Pract. 2012;18(2):86-93.
27. Teitelbaum SA, DuPont RL, Bailey JA, et al. Cannabis use disorders: treatment, prognosis, and long-term medical effects. In: Basow, DS (ed). UpToDate. Waltham, MA: UpToDate; 2012.
28. Hoecker CC, Ewald MB, Wiley JF. Designer drugs of abuse in children and adolescents. In: Basow, DS (ed). UpToDate. Waltham, MA: UpToDate; 2012.
29. Gray KM, Carpenter MJ, Baker NL, et al. A double-blind randomized controlled trial of N-acetylcysteine in cannabis-dependent adolescents. Am J Psychiatry. 2012;169:805-812.
30. Faggiano F, Vigna-Taglianti F, Versino E, et al. School-based prevention for illicit drugs' use. Cochrane Database of Systematic Reviews. 2005. Available at: onlinelibrary. wiley. com/doi/10.1002/14651858.CD003020.pub2/full. Accessed Dec. 3, 2012.